Multiplex Mutation Detection Using Mass Spectrometry in Bladder Cancer

Clinical trial NCT07424560 · RECRUITING

Trial details

NCT number: NCT07424560
Sponsor: Zhilong Dong
Status: RECRUITING
Study type: OBSERVATIONAL

Bladder Cancer Bladder Cancer Recurrence Adjuvant Therapy for Bladder Cancer Progression of Bladder Cancer

Start date: 2026-02-25
Primary completion: 2028-07-01
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.